Kevin L. Espinoza
Chief Integrity & Compliance OfficerMr. Kevin L. Espinoza is Chief Integrity & Compliance Officer of Supernus Pharmaceuticals, Inc. from November 2026. Mr. Espinoza is Chief Integrity & Compliance Officer of Indivior Pharmaceuticals, Inc. (formerly known as Indivior PLC) from October 2025. He served as Chief Integrity Officer of kaleo Inc. until June 2023. Mr. Espinoza served as Chief Compliance Officer at kaleo Inc. since December 2020. He is responsible for overseeing key operations at Kaleo. Mr. Espinoza joined Kaleo from Boston Scientific, where he served as the senior vice president of corporate compliance and a privacy officer. Mr. Espinoza has also served as a global RD compliance officer at Forest Laboratories, vice president and practice leader at Compliance Implementation Services, senior director and North America deputy compliance officer at GlaxoSmithKline and various roles in sales, corporate affairs and marketing at Eli Lilly. Mr. Espinoza has Bachelor's in Political Science from University of Kentucky. Mr. Espinoza has M.B.A. from West Virginia Wesleyan College.
Positions
- Company NameSupernus, Inc.Stock CodeSUPNPositionChief Integrity & Compliance OfficerColleagues
- CHChristian HeidbrederChief Scientific Officer
- SAStuart Anthony KingsleyIndependent Non-Executive Chair
- JAJack A. KhattarPresident, CEO & Director
- TCTimothy C. DecSenior VP & CFO
- JTJason ThompsonVice President of Investor Relations
- JTJuliet ThompsonLead Independent Director
- MPMark P. StejbachIndependent Non-Executive Director
- KHKeith HumphreysIndependent Non-Executive Director
